InspireMD Inc
Company Profile
Business description
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Contact
6303 Waterford District Drive
Suite 215
MiamiFL33126
USAT: +1 888 776-6804
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
66
Stocks News & Analysis
stocks
Market too pessimistic about unloved ASX health care share
stocks
Two overvalued ASX shares to avoid
stocks
Materially undervalued ASX tech share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,899.30 | 6.50 | -0.07% |
| CAC 40 | 8,079.26 | 53.46 | 0.67% |
| DAX 40 | 23,629.29 | 164.66 | 0.70% |
| Dow JONES (US) | 47,329.25 | 216.80 | 0.46% |
| FTSE 100 | 9,682.31 | 72.78 | 0.76% |
| HKSE | 25,928.08 | 33.53 | 0.13% |
| NASDAQ | 23,129.97 | 104.38 | 0.45% |
| Nikkei 225 | 49,559.07 | 899.55 | 1.85% |
| NZX 50 Index | 13,562.01 | 81.58 | 0.61% |
| S&P 500 | 6,797.83 | 31.95 | 0.47% |
| S&P/ASX 200 | 8,606.50 | 9.50 | -0.11% |
| SSE Composite Index | 3,864.18 | 5.84 | -0.15% |